Potent efficacy signals from systemically administered oncolytic herpes simplex virus (HSV1716) in hepatocellular carcinoma xenograft models

Potent efficacy signals from systemically administered oncolytic herpes simplex virus (HSV1716) in hepatocellular carcinoma xenograft models

Lynne Braidwood, Kirsty Learmonth, Alex Graham, Joe Conner Virttu Biologics Ltd, Department of Neurology, Southern General Hospital, Glasgow, UK Abstract: Oncolytic herpes simplex virus (HSV1716), lacking the neurovirulence factor ICP34.5, has highly selective replication competence for cancer cell...

Full description

Bibliographic Details
Main Authors: Braidwood L, Learmonth K, Graham A, Conner J
Format: Article
Language:English
Published: Dove Medical Press 2014-10-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
oncolytic virus
preclinical
xenografts
HCC
systemic
Online Access:https://www.dovepress.com/potent-efficacy-signals-from-systemically-administered-oncolytic-herpe-peer-reviewed-article-JHC

Internet

https://www.dovepress.com/potent-efficacy-signals-from-systemically-administered-oncolytic-herpe-peer-reviewed-article-JHC

Similar Items